SHANGHAI, Sep 7, 2026 – (ACN Newswire) – Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH; 02196.HK) today announced an H share repurchase plan, under which the company intends to repurchase its H shares with an aggregate amount of up to HK$1 billion…
Read More
